0001811468-20-000003.txt : 20201223 0001811468-20-000003.hdr.sgml : 20201223 20201223114853 ACCESSION NUMBER: 0001811468-20-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201223 DATE AS OF CHANGE: 20201223 EFFECTIVENESS DATE: 20201223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Atsena Therapeutics, Inc. CENTRAL INDEX KEY: 0001811468 IRS NUMBER: 845181493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-384201 FILM NUMBER: 201410854 BUSINESS ADDRESS: STREET 1: 701 W MAIN STREET, SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 302-290-5544 MAIL ADDRESS: STREET 1: 701 W MAIN STREET, SUITE 200 CITY: DURHAM STATE: NC ZIP: 27701 D 1 primary_doc.xml X0708 D LIVE 0001811468 Atsena Therapeutics, Inc. 701 W MAIN STREET, SUITE 200 DURHAM NC NORTH CAROLINA 27701 302-290-5544 DELAWARE VectorEyes Therapeutics, Inc. None Corporation true 2019 Patrick Ritschel c/o Atsena Therapeutics, Inc. 701 W Main Street, Suite 200 Durham NC NORTH CAROLINA 27701 Executive Officer Director Michael Dial c/o Atsena Therapeutics, Inc. 701 W Main Street, Suite 200 Durham NC NORTH CAROLINA 27701 Director Benjamin Yerxa c/o Atsena Therapeutics, Inc. 701 W Main Street, Suite 200 Durham NC NORTH CAROLINA 27701 Director Shannon Boye c/o Atsena Therapeutics, Inc. 701 W Main Street, Suite 200 Durham NC NORTH CAROLINA 27701 Director Sanford Boye c/o Atsena Therapeutics, Inc. 701 W Main Street, Suite 200 Durham NC NORTH CAROLINA 27701 Executive Officer Biotechnology Decline to Disclose 06b false 2020-12-15 false true true Preferred stock can convert to underlying shares of Common Stock false 0 55000000 27499973 27500027 false 11 0 0 0 false Atsena Therapeutics, Inc. /s/: Patrick Ritschel Patrick Ritschel Chief Executive Officer 2020-12-23